Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome versus continuous fascia iliaca block for recovery after geriatric hip arthroplasty
ChiCTR2400091379Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Bengbu City
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine and ropivacaine in hip fracture (2 arms), sponsored by The First People's Hospital of Bengbu City. Primary endpoint: Postoperative recovery quality. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
bupivacaineropivacaine
03
Conditions
hip fracture
Beyond the preview
Go deeper on ChiCTR2400091379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091379.